23 April 2020 | 1 min. readingtime
Pharmaceutical companies around the world are doing everything they can to develop tests, a vaccine and medication to fight the coronavirus. As a committed shareholder, we, together with other parties, call on the pharmaceutical sector to pursue maximum collaboration in order to minimise the spread of the virus and its consequences worldwide. We call on them to seek maximum collaboration with each other, public authorities and research centres to that end, and not to allow themselves to be guided by short-term financial motives. That is the gist of our investor statement, which we are publishing together with close to 40 other national and international portfolio management companies, pension funds and insurance companies, with more than € 1,400 billion under management. Only together can we defeat the coronavirus.
Click the link below to read the investor statement (PDF).
18 December 2020 | 1 min. readingtime
With each new technological advance or new insight into the effect of sustainability themes on the social value that companies create or destroy, expectations change.
27 October 2020 | 2 min. readingtime
With just a few days to go until 3 November, we take stock again. What has changed since then, and how are prospects now in our view?
25 September 2020 | 1 min. readingtime
a.s.r. has signed the Finance Biodiversity Pledge. With this initiative, a group of financial institutions is supporting various actions to reverse nature loss as much as possible in this decade.
